Matthew L. Goodwin
Duke University(US)Duke Medical Center(US)
Publications by Year
Research Areas
Cytomegalovirus and herpesvirus research, Herpesvirus Infections and Treatments, Parvovirus B19 Infection Studies, Lymphoma Diagnosis and Treatment, Innovations in Medical Education
Most-Cited Works
- → The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity(2019)69 cited
- → Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization(2020)61 cited
- → Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans(2020)51 cited
- → The Effect of HIV and HPV Coinfection on Cervical COX-2 Expression and Systemic Prostaglandin E2 Levels(2011)45 cited
- → Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection(2020)20 cited
- → The Duke Hotspotting Initiative: Providing Meaningful Clinical Experiences and Improving Clinical Readiness for First-Year Medical Students(2020)7 cited
- → HCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization(2019)3 cited
- → P-2149. Cryptococcosis in Patients with Hematologic Malignancy: Guideline-Based Treatment Regimens and Mortality of a 30-year Cohort at Duke(2026)
- → 2772. HCMV gB Ectodomain Subunit and gB mRNA Vaccines Reduce AD-3 Immunodominance and Elicit More Durable Antibody Responses Than gB/MF59 Immunization(2019)